Risk assessment of opioid misuse in Italian patients with chronic noncancer pain

Pain Research and Treatment

Volumn 2014, Issue , 2014, Pages

  Ferrari, Renata ^a   Duse, Genni ^b   Capraro, Michela ^a   Visentin, Marco ^a  

^a SAN BORTOLO HOSPITAL   (Italy)

^b S ANTONIO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84907416136     PISSN: 20901542     EISSN: 20901550     Source Type: Journal    
DOI: 10.1155/2014/584986     Document Type: Article

References (34)

1. H. Breivik, B. Collett, V. Ventafridda, R. Cohen, and D. Gallacher, "Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment," European Journal of Pain, vol. 10, no. 4, pp. 287-333, 2006.
2. E. Kalso, L. Allan, P. L. I. Dellemijn et al., "Recommendations for using opioids in chronic non-cancer pain," European Journal of Pain, vol. 7, no. 5, pp. 381-386, 2003.
3. J. C. Ballantyne, "Opioid analgesia: perspective on right use and utility," Pain Physician, vol. 10, no. 3, pp. 479-491, 2007.
4. J. A. Boscarino, M. Rukstalis, S. N. Hoffman et al., "Risk factors for drug dependence among out-patients on opioid therapy in a large US health-care system," Addiction, vol. 105, no. 10, pp. 1776-1782, 2010.
5. M. von Korff, A. Kolodny, R. A. Deyo, and R. Chou, "Long-term opioid therapy reconsidered," Annals of Internal Medicine, vol. 155, no. 5, pp. 325-328, 2011.
6. R. N. Jamison, J. Serraillier, and E. Michna, "Assessment and treatment of abuse risk in opioid prescribing for chronic pain,"Pain Research and Treatment, vol. 2011, Article ID 941808, 12 pages, 2011.
7. International Narcotic Control Board, Narcotic Drugs Estimated World Requirement for 2005, Statistics for 2003, INCB, New York, NY, USA, 2005.
8. L. Webster, B. St. Marie, B. McCarberg, S. D. Passik, S. J. Panchal, and E. Voth, "Current status and evolving role of abuse-deterrent opioids in managing patients with chronic pain,"Journal of Opioid Management, vol. 7, no. 3, pp. 235-245, 2011.
9. R. Chou, J. C. Ballantyne, G. J. Fanciullo, P. G. Fine, and C. Miaskowski, "Research gaps on use of opioids for chronic noncancer pain: findings from a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline," Journal of Pain, vol. 10, no. 2, pp. 147-159, 2009.
10. J. Højsted and P. Sjøgren, "Addiction to opioids in chronic pain patients: a literature review," European Journal of Pain, vol. 11, pp. 490-518, 2007.
11. R. Ferrari, M. Capraro, and M. Visentin, "Risk factors in opioid treatment of chronic non-cancer pain: a multidisciplinary assessment," in Pain Management-Current Issues and Opinions, B. R. Racz and C. E. Noe, Eds., pp. 419-458, Intechopen.com, Austin, Tex, USA, 2011.
12. L. L. Adams, R. J. Gatchel, R. C. Robinson et al., "Development of a self-report screening instrument for assessing potential opioid medication misuse in chronic pain patients," Journal of Pain and Symptom Management, vol. 27, no. 5, pp. 440-459, 2004.
13. M. J. Belgrade, C. D. Schamber, and B. R. Lindgren, "The DIRE score: predicting outcomes of opioid prescribing for chronic pain," Journal of Pain, vol. 7, no. 9, pp. 671-681, 2006.
14. A. K. Buelow, R. R. Haggard, and R. J. Gatchel, "Additional validation of the pain medication questionnaire in a heterogeneous sample of chronic pain patients," Pain Practice, vol. 9, no. 6, pp. 428-434, 2009.
15. L. S. Dowling, R. J. Gatchel, L. L. Adams, A. W. Stowell, and D. Bernstein, "An evaluation of the predictive validity of the Pain Medication Questionnaire with a heterogeneous group of patients with chronic pain," Journal of Opioid Management, vol. 3, no. 5, pp. 257-265, 2007.
16. S. R. Hathaway and J. C. McKinley, MMPI-2: Manual for Administration and Scoring, University of Minnesota Press, Minneapolis, Minn, USA, 1989.
17. P. Pancheri, S. Sirigatti, and M. Biondi, "Adaptation of the MMPI- 2 in Italy," in International Adaptations of the MMPI-2: Research and Clinical Applications, J. N. Butcher, Ed., pp. 416-441, University of Minnesota Press, Minneapolis, Minn, USA, 1996.
18. A. T. Beck, R. A. Steer, and G. K. Brown, Manual for the Beck Depression Inventory,The Psychological Corporation, San Antonio, Tex, USA, 2nd edition, 1996.
19. M. Ghisi, G. B. Flebus, A. Montano et al., Beck Depression Inventory, Adattamento Italiano: Manuale, Giunti Organizzazioni Speciali, Florence, Italy, 2nd edition, 2006.
20. C. D. Spielberger, State-Trait Anxiety Inventory for Adults, Edited by M. Garden, 1983.
21. L. Pedrabissi and M. Santinello, STAI, State-Trait Anxiety Inventory, Forma Y: Manuale, Giunti Organizzazioni Speciali, Firenze, Italy, 1996.
22. H. Flor and D. C. Turk, "Chronic back pain and rheumatoid arthritis: predicting pain and disability from cognitive variables,"Journal of Behavioral Medicine, vol. 11, no. 3, pp. 251-265, 1988.
23. R. Ferrari, E. Fipaldini, and N. Birbaumer, "La valutazione del controllo percepito sul dolore: la versione italiana del Pain Related self-Statement Scale e del Pain Related Control Scale,"Giornale Italiano di Psicologia, vol. 1, pp. 187-208, 2004.
24. RJ. Gatchel, Clinical essentials of pain management, American Psychological Association, Washington DC, 2005.
25. J. Dersh, R. J. Gatchel, T. Mayer, P. Polatin, and O. R. Temple, "Prevalence of psychiatric disorders in patients with chronic disabling occupational spinal disorders," Spine, vol. 31, no. 10, pp. 1156-1162, 2006.
26. D. L. Haller and M. C. Acosta, "Characteristics of pain patients with opioid-use disorder," Psychosomatics, vol. 51,no. 3, pp. 257-266, 2010.
27. A. M. Trescot, S. Helm, H. Hansen et al., "Opioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians? (ASIPP) guidelines," Pain Physician, vol. 11, S5, no. 2, p. S62, 2008.
28. C. P. Holmes, R. J. Gatchel, L. L. Adams et al., "An opioid screening instrument: long-term evaluation of the utility of the pain medication questionnaire," Pain Practice, vol. 6, no. 2, pp. 74-88, 2006.
29. P. Compton, J. Darakjian, and K. Miotto, "Screening for addiction in patients with chronic pain and "problematic" substance use: evaluation of a pilot assessment tool," Journal of Pain and Symptom Management, vol. 16, no. 6, pp. 355-363, 1998.
30. M. D. Sullivan, M. J. Edlund, L. Zhang, J. Unützer, and K. B. Wells, "Association between mental health disorders, problem drug use, and regular prescription opioid use," Archives of Internal Medicine, vol. 166, no. 19, pp. 2087-2093, 2006.
31. L. Manchikanti, K. A. Cash, K. S. Damron, R. Manchukonda, V. Pampati, and C. D. McManus, "Controlled substance abuse and illicit drug use in chronic pain patients: an evaluation of multiple variables," Pain Physician, vol. 9, no. 3, pp. 215-226, 2006.
32. H. A. Heit and D. L. Gourlay, "Urine drug testing in pain medicine,"Journal of Pain and Symptom Management, vol. 27, no. 3, pp. 260-267, 2004.
33. T. J. Ives, P. R. Chelminski, C. A. Hammett-Stabler et al., "Predictors of opioid misuse in patients with chronic pain: a prospective cohort study," BMC Health Services Research, vol. 6, article 46, 2006.
34. E. Michna, R. N. Jamison, L. Pham et al., "Urine toxicology screening among chronic pain patients on opioid therapy: frequency and predictability of abnormal findings," The Clinical Journal of Pain, vol. 23, no. 2, pp. 173-179, 2007.